BNTX vs VRTX: Which Stock is Better?

Side-by-side comparison of Biontech Se and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

BNTX

Biontech Se

$101.95

VRTX

Vertex Pharmaceuticals Inc

$460.82

Key Metrics Comparison

MetricBNTXVRTXWinner
Market Cap$25.58B$117.05BVRTX
P/E RatioN/A30.12VRTX
EPS (TTM)$N/A$15.30VRTX
Revenue Growth0.2%0.1%BNTX
Gross Margin82.5%53.7%BNTX

Analyze BNTX

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BNTX or VRTX a better investment?

Comparing BNTX and VRTX: Biontech Se has a market cap of $25.58B while Vertex Pharmaceuticals Inc has $117.05B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BNTX and VRTX?

BNTX (Biontech Se) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BNTX or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: BNTX or VRTX?

BNTX has higher revenue growth at 0.2% vs 0.1% for VRTX.

Which company is more profitable: BNTX or VRTX?

Biontech Se (BNTX) has higher gross margins at 82.5% compared to 53.7% for VRTX.

Which is the larger company: BNTX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $117.05B compared to $25.58B for BNTX.

Should I buy BNTX or VRTX in 2026?

Both BNTX and VRTX have investment merit. BNTX trades at $101.95 while VRTX trades at $460.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BNTX and VRTX stock?

Key differences: Market Cap ($25.58B vs $117.05B), P/E Ratio (N/A vs 30.1x), Revenue Growth (0.2% vs 0.1%), Gross Margin (82.5% vs 53.7%).

Popular Stock Comparisons